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A wide variety of soluble signaling substances utilize the cyclic AMP-dependent protein kinase (PKA) pathway to regulate cellular
behaviors including intermediary metabolism, ion channel conductivity, and transcription. A growing literature suggests that integrin-
mediated cell adhesion may also utilize PKA to modulate adhesion-associated events such as actin cytoskeletal dynamics and migration.
PKA is dynamically regulated by integrin-mediated cell adhesion to extracellular matrix (ECM). Furthermore, while some hallmarks of cell
migration and cytoskeletal organization require PKA activity (e.g. activation of Rac and Cdc42; actin filament assembly), others are inhibited
by it (e.g. activation of Rho and PAK; interaction of VASP with the c-Abl tyrosine kinase). Also, cell migration and invasion can be impeded
by either inhibition or hyper-activation of PKA. Finally, a number of A-kinase anchoring proteins (AKAPs) serve to associate PKA with
various components of the actin cytoskeleton, thereby enhancing and/or specifying cAMP/PKA signaling in those regions. This review
discusses the growing literature that supports the hypothesis that PKA plays a central role in cytoskeletal regulation and cell migration.
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1. Introduction Eachof these physically and spatiallydistinct steps requires, inCell movement is a truly Byzantine process [1–4], requir-
ing coordination of cell adhesion to extracellular matrix
(ECM), cytoskeletal assembly and disassembly, membrane
protrusion and retraction. It has traditionally been broken
down into four fundamental steps—(1) protrusion of a leading
edge, (2) adhesionof that edge toECM, (3) translocationof the
cell body, and (4) release and/or retraction of the trailing edge.0167-4889/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2004.03.005
Abbreviations: AKAP, A-kinase anchoring protein; cAMP, cyclic
adenosine monophosphate; CAS, Crk-associated substrate; cGMP, cyclic
guanosine monophosphate; ECM, extracellular matrix; EVH, Ena/VASP
homology; EPAC, exchange protein activated by cAMP; ERK, extracellular
signal regulated kinase; FAK, focal adhesion kinase; FRET, fluorescence
resonance energy transfer; GFP, green fluorescent protein; GPCR, G-
protein coupled receptor; GTPase, guanosine triphosphatase; Lbc, lym-
phoid blast crisis; MLC, myosin light chain; MLCK, MLC kinase; PAK,
p21-activated kinase; PI3-K, phosphotidylinositol 3-kinase; PKA, protein
kinase A (cAMP-dependent protein kinase); PRR, proline-rich region; PTP,
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homology; SSeCKS, Src-suppressed C-kinase substrate; WASP, Wiskott –
Aldrich Syndrome protein; WAVE, WASP and verprolin homology protein;
VASP, vasodilator-stimulated phosphoprotein
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E-mail address: Alan.Howe@uvm.edu (A.K. Howe).turn, a very distinct panel of biochemical events to ensure a
pattern of movement that is both efficient and able to be
dynamically regulated (i.e. in speed and direction). Thus,
spatial regulation of internal cellular signaling processes is
crucial for efficient directional cell movement [1–5].
The current profusion of GFP- and FRET-based imag-
ing technologies [6–11] has initiated a list of proteins
whose activity is spatially regulated cell migration and
cytoskeletal reorganization [11]. To date, these proteins are
almost exclusively those whose function(s) had already
been relegated to controlling some aspect of regulation of
the cytoskeleton or cell movement. Prominent examples
include the Rho family GTPases Cdc42, Rac, and Rho
[12–15]. For example, it is not particularly surprising that
Rac activation occurs within protruding lamellipodia [15],
since it is well established that the principal function of
Rac is to promote formation of these structures [16].
Certainly, such studies have been extremely helpful in
confirming various proteins’ roles in cell movement and
in defining or refining the spatiotemporal kinetics of their
function. However, given the complexity of cell move-
ment, is it extremely likely that many other proteins—
including those with myriad activities beyond cytoskeletal
regulation—may impinge on the function of the ‘usual
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tion of the cytoskeleton and cell movement.
A prime example of this is the cAMP-dependent pro-
tein kinase, PKA, a truly venerable enzyme at the center
of the first signal transduction cascade ever defined
[17,18]. PKA is extremely promiscuous with its activity
[19], with targets in the membrane, cytoplasm, mitochon-
dria, nucleus, and most germane here, nearly every family
of cytoskeletal network, including microtubules, interme-
diate filaments, and actin microfilaments—the focus of
this article. Because the consequences of PKA activity are
many and because the targets for PKA activity are
scattered far and wide about the cellular landscape, the
need for focusing or specifying PKA activity is ostensibly
greater, although perhaps less obvious, than for proteins
dedicated to cytoskeletal regulation. The importance of
tight control and specificity of PKA activity during cell
migration is supported by reports that both preternatural
stimulation and inhibition of PKA have negative effects
on the migration of several cells types (see Refs. [20–22]
and later sections).
The intention of this article is to make the reader aware,
or perhaps simply more aware, of the rich potential for
cAMP/PKA signaling in the regulation of actin-dependent
cell migration and to offer a list, albeit an unquestionably
incomplete one, of important cytoskeletal and adhesive
targets over which cAMP/PKA may preside.
A brief verbiage disclaimer. The term ‘cAMP/PKA’ is
used herein to connote the signaling axis defined by
increased intracellular cAMP activating its kinase. This is
not meant to suggest that cAMP and PKA are inexorably
linked and identical in their actions. Indeed, this article
makes significant mention of the potential importance of
PKA-independent effects of cAMP, and more casual men-
tion of cAMP-independent activation of PKA. The focus
here is, again, the effects of the canonical signaling pathway
on cytoskeletal dynamics and migration, with full recogni-
tion that the field is not closed to new paradigms of cAMP
and/or PKA function.2. Historical perspective/background
2.1. PKA structure and function
PKA is a heterotetrameric enzyme comprising two
regulatory (R) and two catalytic (C) subunits. Four R
subunits are encoded by four separate genes (RIa, RIh,
RIIa, RIIh), while three genes (a, h, and g) comprise the
C subunit family. Two types of PKA holoenzyme—type I
and type II—are defined by the type of R subunit. The R
subunits have four major functions. First, they maintain the
holoenzyme in an inactive state by inserting a pseudo-
substrate (for RI subunits) or true substrate (for RII
subunits) domain into the C subunit catalytic cleft. Second,
R subunits release active C subunit upon cooperativebinding of two molecules of cAMP per molecule of R.
Thus, R subunits are proximally responsible for translating
intracellular cAMP levels into phosphotransferase activity.
Third, the N-terminus of each R subunit mediates dimer-
ization, which directs assembly of the heterotetrameric
holoenzyme and is crucial for cooperative binding of
cAMP. This N-terminal dimerization domain is coincident
with the domain that mediates the fourth major R subunit
function, namely interaction with A-kinase anchoring pro-
teins, or AKAPs.
Members of the functionally related but structurally
diverse AKAP family compartmentalize PKA—typically,
but not always, the RII-containing holoenzyme—to various
subcellular regions or structures, and thus provide an
invaluable measure of specificity to cAMP/PKA signaling
[23,24]. In addition to localization, many AKAPs direct the
assembly of multi-enzyme complexes that serve as pre-
assembled circuits capable of integrating multiple, diverse
input signals to control the phosphorylation of a given target
with exquisite specificity [24]. Often, these circuits are
composed of enzymes with opposing actions or effects on
the same target, allowing tight, localized, and dynamic
control over effector function. Importantly, several such
circuits juxtapose PKA with principal regulators of actin
cytoskeletal dynamics (e.g. those involving the AKAPs
WAVE-1 and AKAP-Lbc [25,26]) and are discussed in
more detail in subsequent sections.
A complimentary line of investigation has revealed that
distinct cAMP signals can also occur within different
subcellular regions [27]. Furthermore, type I PKA has
higher affinity for cAMP than does type-II [28]. This lends
itself to a simple but highly plausible hypothesis in which
the lower affinity of type-II PKA allows the anchored
enzyme to respond to only sharp, local gradients of cAMP,
and thus form distinct, location-specific nodes for inter-
preting and disseminating spatially distinct cAMP signals.
This potential for spatial signaling specificity positions
cAMP/PKA well for playing a significant role in cell
migration, a cellular activity that absolutely requires the
distribution of different enzymatic activities to different
subcellular locations.
2.2. General effects of cAMP/PKA in cell migration
Historically, there is a dichotomy in the role of PKA in
cytoskeletal organization and cell migration, exerting both
negative (i.e. inhibitory) and positive (i.e. required or
enhancing) effects. Agonists of cAMP/PKA signaling have
long been noted to cause significant changes in cellular
architecture, such as dissolution of stress fibers and induc-
tion of stellate morphology in neurons and other cells [29–
31]. Negative effects of PKA on migration have been
reported for avh3-dependent endothelial cell migration on
vitronectin [32], although there also is evidence that sup-
ports a positive role (see Ref. [33] and below). Also, matrix-
specific down-regulation of cAMP/PKA signaling appears
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stress fiber formation in endothelial cells [34].
Conversely, elevation of cAMP and activation of PKA
have been shown to be required for efficient cell migration,
or hallmark steps of migration, in several systems as well.
These include: formation of filopodia and lamellipodia in
response to follicle stimulating hormone [35]; mammary
epithelial cell migration on laminin [36]; microfilament
assembly [37]; and activation of Cdc42 and Rac [38,39].
In addition, the motility of HeLa cells correlates with
cyclooxygenase-mediated metabolism of arachidonic acid,
activation of PKA, and the consequent formation of focal
adhesion-associated actin bundles rich in myosin II [40].
It seems rather clear that in most cell types, it is not
simply a matter of cAMP/PKA signaling exerting a blanket
negative or positive effect on the cytoskeleton or cell
migration. Rather, it appears that a balance of cAMP/PKA
activity—either in extent, space, time, or all three—is
crucial for successful cell movement [21,22,39].3. Regulation of cAMP/PKA during adhesion and
migration
3.1. Regulation of activity by cell adhesion
The cAMP/PKA pathway is dynamically regulated by
integrin-mediated adhesion to the ECM. PKA is robustly,
but transiently activated by cellular detachment, and inhi-
bition of this activity can delay the inactivation of certain
anchorage-dependent enzymes (e.g. ERK, PAK, FAK, and
paxillin) [41]. Conversely, cAMP/PKA signaling is also
activated following integrin-mediated adhesion in a number
of cell types [37,39,42], although this effect appears to be
much more variable. Indeed, an excellent recent investiga-
tion [34] showed the regulation of cAMP/PKA signaling by
cell adhesion to be both ECM- and cell type-specific.
Specifically, cAMP/PKA was actually suppressed in endo-
thelial cells plated on collagen I but not on laminin-1, and
also not in fibroblasts plated on collagen. In addition,
adhesion through the h1 integrin (most likely a5h1) appears
to suppress PKA activity during avh3-mediated endothelial
cell migration on vitronectin [32], but can activate PKA in
fibroblasts [42], fibrosarcoma cells [37], and carcinoma
cells [39]. There is also evidence that cAMP/PKA signaling
can be initiated by relaxation of cytoskeletal stress, i.e.
release of cell–ECM counter-tension, through a mechanism
involving phospholipase D and phosphatidic acid produc-
tion [43,44]. This effect may also contribute to the activa-
tion of PKA following cellular detachment from ECM
[41,42].
It is interesting to note that there is considerable agree-
ment between the various reported time courses for adhe-
sion-mediated regulation of cAMP/PKA activity [34,37,39,
41,42] and the time courses for adhesion-mediated suppres-
sion of Rho [45,46] and activation of Rac and Cdc42[47,48]. This intriguing correlation fits very well with the
reported negative and positive effects of PKA on these
proteins (discussed in a later section).
Although it is clear that cAMP/PKA are dynamically
regulated by cell adhesion and during cell migration, the
mechanism(s) through which cAMP/PKA becomes activat-
ed during these processes remain quite unclear. The best
direct investigations into the mechanism of integrin-medi-
ated control of cAMP/PKA have come from the laboratories
of A. Mercurio and W. Frazier. During migration of carci-
noma cells, the a6h4 integrin appears to decrease intracel-
lular cAMP by activating a rolipram-sensitive (i.e. likely
type-IV) phosphodiesterase (PDE), thus promoting the for-
mation of lamellapodia [49]. In smooth muscle cells, integ-
rin-associated protein (IAP or CD47), so named for its
interaction with avh3 and aIIbh3 integrins [50], decreases
intracellular cAMP through a Gi-dependent mechanism and
thus enhances integrin a2h1-mediated migration towards
soluble collagen [51]. Its critical role in smooth muscle cell
migration and its origins as a h3-associated protein suggest
that IAP may also contribute to avh3-dependent, PKA-
modulated migration, such as that seen in endothelial cells
(see Ref. [33] and Section 2.2).
3.2. Regulation of location
In previous sections, the requirement for spatial specific-
ity in PKA signaling during cell migration was founded. As
compartmentalization of PKA signaling is mediated largely
(although not exclusively—see below) by AKAPs, this
establishes the function of the relevant AKAPs as an
important facet of PKA-mediated cytoskeletal dynamics
and cell migration. Localization or spatial restriction of
cAMP/PKA signaling can also occur through interaction
of components of the pathway, including PKA itself, with
caveolin-rich microdomains [52–55]. This alternate mech-
anism of localization notwithstanding, the connections be-
tween AKAPs and the cytoskeleton and their potential
importance for cell movement have been recently and
expertly reviewed [23,56]. Therefore, this topic will be only
briefly revisited here.
To date, the AKAPs that have been convincingly linked,
either physically or functionally, to the actin cytoskeleton
include the following: AKAP-Lbc/AKAP13 [57,58], which
is the full-length clone of the originally identified Ht31
AKAP [59]; gravin [60] and the closely related SSeCKS
(Src-suppressed C-kinase substrate) [61]; ezrin [62]; AKAP-
KL (AKAP expressed in kidney and lung) [63]; and the
WASp and verprolin homology protein-1 (WAVE1) [26].
All of these AKAPs except AKAP-Lbc have been shown to
physically interact or co-localize with the actin cytoskeleton
(gravin/SSeCKS [64–66], WAVE1 [67,68], ezrin [69–71],
AKAP-KL [23,63]). AKAP-Lbc, on the other hand, has a
close functional link with the actin cytoskeleton through its
interaction with the Rho GTPase and ability to promote
GPCR-dependent stress fiber formation [57,58].
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and overexpression of SSeCKS can promote the formation
of filopodia as well as cell flattening [65,66]. Ezrin, one of
the founders of the ezrin/radixin/moesin family of proteins
[70], localizes to filopodia and membrane ruffles [72–74],
helps link actin microfilaments to the cell membrane
[70,75], and plays an important role in regulating the
GTPases Rho and Rac [76,77]. Much less is known about
the newcomer AKAP-KL, except that it is enriched in the
inner apical surface of polarized epithelium and appears to
co-localize with F-actin [63].
The WAVE1 protein represents a particularly interesting
case (reviewed in depth in Ref. [56]). WASP/WAVE pro-
teins play crucial roles in coupling Rho GTPases (specifi-
cally Cdc42 and Rac) to actin filament assembly [4,67], and
localize to lamellipodial leading edges [78]. In addition to
its ability to bind PKA RII subunits, WAVE1 can the c-Abl
tyrosine kinase, thus forming a multi-enzyme complex [26].
This scaffolding function of WAVE1 may underlie, at least
in part, the redistribution of both PKA and Abl to areas of
growth factor-stimulated cytoskeletal rearrangement, espe-
cially dorsal membrane ruffles [26]. This complex is of
particular interest, given the ability of PKA to phosphorylate
another cytoskeletal regulatory protein, the vasodilator-
stimulated phosphoprotein (VASP), and disrupt its interac-
tion with Abl (see Ref. [42] and below). Thus, it is possible
that PKA, localized and scaffolded by WAVE1, may control
the balance of WAVE–Abl and VASP–Abl complexes.
The substantial catalog of actin-associated AKAPs pro-
vides a strong prima facie case for the importance of both
PKA activity and spatial regulation of that activity for
cytoskeleton-dependent process such as cell migration. As
a note of proof, a very compelling example of the importance
of AKAP-mediated localization of PKA activity for accurate
cytoskeletal regulation in vivo has come from Drosophila,
wherein disruption of AKAP200 causes enlargement and
thinning of the actin-rich ring canals that connect germ cells
during oogenesis [79]. Interestingly, mutations in this AKAP
suppress ring canal phenotypes caused by a mutation in Src
[79], raising an intriguing potential connection between
PKA and Src function (see below).4. Targets for PKA in regulation of the cytoskeleton and
migration
A few notes of pre-clarification—While all of the
following are indeed bona fide targets for cAMP/PKA
signaling, based on published investigations, several of the
consequences of regulation of these that are proffered here
are hypothetical, or in a more positive light, yet to be
proven. Though hypothetical, they are based on sound
theory, the known functions of the target under consider-
ation, and extrapolation of the effect of PKA on the target
out to the target’s downstream effectors. Finally, the targets
considered in this article have been relegated to two broadcategories—structural and regulatory proteins. This is
simply for the sake of organization, not for definitive
classification.
4.1. Filament/structural proteins
4.1.1. Actin
At the very heart of the connection between PKA and
microfilament regulation is the ability of PKA to directly
phosphorylate monomeric actin, a modification that signif-
icantly decreases monomer ‘polymerizibility’ in vitro [80].
While the description of this phosphorylation event is
somewhat dated and has not yet been extrapolated to actin
polymerization in vivo, the data are solid and compelling
and do provide a wonderfully linear path for regulation of
actin dynamics by PKA.
4.1.2. a4 Integrin
The a4 integrins (a4h1 and a4h7) are expressed predom-
inantly in neural crest cells, skeletal and smooth muscle cells,
and various immune cells, where they contribute to embry-
onic and cardiovascular development and function, as well as
in the immune response [81,82]. Major advances in the
understanding of a4 integrin function have come from the
demonstrations that its cytoplasmic tail interacts directly with
paxillin [83], and that this interaction can modulate a4h1
effects on cell migration [83–85]. Importantly, a4-paxillin
interaction is negatively regulated by phosphorylation of the
a4 tail [84], an event mediated directly by PKA [86]. In
addition, PKA-dependent a4 phosphorylation occurs pre-
dominantly within protrusive, lamellipodial structures and
is critical for a4h1-dependent cell migration [86]. Though the
sequence targeted by PKA in the a4 tail (neighboring Ser988)
is not present in other integrin a-subunit tails [84], PKA-
dependent phosphorylation of a4 appears to play a central
role in the migratory function governed by this integrin, and
will therefore likely be important for a4-dependent functions
in vivo.
4.1.3. VASP
VASP is the patriarch of a family of cytoskeletal
regulatory proteins that, in mammals, includes the mam-
malian homolog of the Drosophila Ena protein (Mena) and
the Ena/VASP-like protein Evl [87,88]. All of the proteins
have a common three domain structure comprising an N-
terminal Ena/VASP homology (EVH)-1 domain, a C-ter-
minal EVH-2 domain, and a central proline-rich region
(PRR). VASP family proteins localize to focal adhesions,
largely through EVH1-mediated interaction with proteins
such as vinculin, zyxin, and palladin [87–89] and to
filopodial tips and lamellipodial edges through a less clear
mechanism that may involve both the EVH-1 and EVH-2
domains [78,88,90,91]. The EVH-2 domain also mediates
homo- and heterotypic oligomerization among VASP pro-
teins [92], as well as the ability of the protein to bind,
bundle, and nucleate actin filaments [92–94]. The PRR
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binding protein profilin [95–97], and with the SH3
domains of Abl and Src-family tyrosine kinases and the
WW domain of the FE65 adapter protein [95,96,98].
While the exact nature of the contribution of VASP
proteins to actin dynamics and cell migration is still under
investigation, it is likely that their ability to nucleate and/or
bind filaments will prove critically important [93,99].
There is also elegant evidence that at least one member,
Mena, regulates actin filament capping within protruding
lamellipodia, which in turn controls filament length and
strength, and thus lamellipodial speed and persistence
[100,101].
Importantly, all mammalian VASP proteins are substrates
for PKA, with the preferred site of phosphorylation occur-
ring in or near the PRR [87,88,102]. Importantly, phosphor-
ylation of VASP proteins appears to be critical for their
function during cell migration [99], and is dynamically
regulated by cell adhesion and during cell spreading [42].
For murine VASP, phosphorylation occurs at three residues:
Ser-153 near the Pro-rich region and Ser-235 and Thr-274 in
EVH-2. Although each site can be modified by both PKA
and the cGMP-dependent protein kinase (PKG), Ser-153 is
the preferred target for PKA [102,103]. Only two of these
sites, corresponding to Ser-153 and Ser-235, are present in
Mena, whereas Evl contains only a single, Ser-153-like site.
PKA-mediated phosphorylation of VASP and Evl effective-
ly decreases their ability to nucleate, bind, and bundle actin
filaments [93,98,104].
Phosphorylation near the PRR of VASP proteins also
regulates interactions with SH3 domains. For example,
phosphorylation of Evl by PKA has been shown to abolish
its interaction with Abl and neuronal Src SH3 domains in
vitro [98], while adhesion-dependent PKA activity regulates
VASP–Abl interaction in vivo [42]. Thus, the interaction of
VASP proteins with SH3 domains may represent a specific
target for regulation by PKA. While there is clear in vitro
and in vivo evidence for PKA-mediated regulation of
VASP–Abl interaction, the biochemical consequences of
this interaction on the function of either protein are currently
unknown. Also, despite the in vitro data, there is no
evidence for VASP–Src interaction in vivo [42]. While
the longest, neuronal isoform of Mena is tyrosine-phosphor-
ylated [95], perhaps by Abl with help from Abl-interacting
protein Abi-1 [105], the consensus site for this modification,
along with any evidence of phosphotyrosine content, is
absent from all other mammalian VASP family members
[87,88,95]. Thus, the physiological role of PKA-mediated
regulation of VASP–Abl interaction awaits further charac-
terization. As both VASP and Abl have been shown to
localize to focal adhesions [106,107], filopodial tips [108]
and membrane ruffles [109], disruption of VASP–Abl
interaction may alter their location. This would be particu-
larly intriguing with regard to spatial regulation of Abl
activity [110]. Also, many other relevant binding partners
have been reported for both VASP proteins (discussedabove) and Abl (e.g. Abi-1 and -2 [111,112], Crk and
p130CAS [113], paxillin [107], g-PAK [114], WAVE-1
[26]). Thus, interactions with these or other binding partners
might be in equilibrium with VASP–Abl interaction, and
thus regulated by PKA activity. The potential for PKA-
dependent regulation of Abl function is of particular inter-
est, given the importance of Abl in several facets of actin-
driven cell migration [115] (e.g. filopodial outgrowth [116],
membrane ruffling [109], regulating Crk–p130CAS com-
plexes [117]) and the ability of both PKA and Abl, in
mutant forms, to preside over anchorage-independent sig-
naling and cell growth [41,118].
4.1.4. LASP
A relative newcomer to the list, the LIM- and SH3-
domain containing protein (LASP) was first identified as a
potential cytoskeletal PKA substrate in gastric fibroblasts
and gastric parietal cells [119]. In the former, LASP is
localized to lamellipodial edges and membrane ruffles,
while in the latter, cAMP-dependent phosphorylation of
LASP regulates its translocation to areas of dynamic actin
filaments synthesis. This translocation appears to be impor-
tant for acid secretion in parietal cells, and perhaps other
transmembrane ionic events in other epithelia. More recent
studies have shown that phosphorylation of LASP at Ser146
by either PKA or PKG decreases its interaction with F-actin
in vitro [120,21], while a phosphomimetic Ser-Asp mutation
at this site promotes redistribution of LASP from peripheral
sites (i.e. lamellae and cell–cell contacts) to the cytosol
[121]. Two additional observations underscore the consid-
eration of LASP as an important cytoskeletal PKA substrate.
First, altered expression of LASP is associated with a subset
of breast cancers [122] and, as a fusion with the MLL gene,
with some acute myeloid leukemias [123]. Second, over-
expression of the phosphomimetic mutant inhibits fibroblast
migration [121].
4.1.5. Myosin light chain (MLC)
Myosin-based contractility is important for several
aspects of cell movement, including retraction of the
trailing edge [124] and less well-defined (but no less
important) functions within the leading edge [125,126].
There are several nodes in the regulation of myosin
phosphorylation upon which PKA may exert a level of
control. Indeed, the regulation of myosin phosphorylation
and its real and potential control by PKA has been
comprehensively reviewed elsewhere [127,128], and there-
fore will be only fleetingly dealt with here. MLC interac-
tion with F-actin and myosin-dependent contractility is
positively regulated by phosphorylation. MLC phosphory-
lation is proximally controlled by the ratio of MLC kinase
(MLCK) and MLC phosphatase (MLCP) activities [129].
The regulation of MLCK and MLCP is intensely complex
[129], but highlights allow connections to cAMP and PKA
to be made. MLCK binds to and is activated by the Ca2 +-
calmodulin (CaM) complex. PKA can regulate Ca2 +
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forms of phospholipase C and receptors for inositol tri-
sphosphate (IP3) [130]. This may then modulate the
formation of CaM complexes, and thus MLCK activity.
Interestingly, the interaction of CaM with MLCK may also
be negatively regulated by PKA, as consensus sites for
PKA phosphorylation of MLCK reside in the CaM-binding
region [131,132]. On the other side of the equilibrium,
cAMP and PKA can up-regulate MLCP activity directly
and can alleviate the ROCK-dependent inhibition of
MLCP through phosphorylation and inhibition of Rho
[127,129]. As described here, the influence of PKA on
MLCK and MLCP would both have the same net effect of
decreasing MLC phosphorylation, MLC–microfilament
interaction, and actomyosin-based contractility, consistent
with the oft-observed effects of cAMP/PKA agonists on
stress fibers (see Sections 2.2 and 4.3.1.1 and Ref. [133]).
This does, however, conflict with a recently reported PKA-
dependent assembly of myosin II-rich actin bundles at
focal complexes stimulated by cyclooxygenase-mediated
arachidonic acid metabolism [40]. This contradiction not-
withstanding, the central role of myosin as the actin-
associated motor protein places it high on the list of
relevant targets for PKA activity in cytoskeletal regulation
and migration.
4.2. Regulatory/signaling proteins
4.2.1. Rho GTPases
The Rho family of small GTPases, including various
forms of Cdc42, Rac, and Rho, are involved intimately in
the regulation of the actin cytoskeleton. Several excellent
reviews describe practically every aspect of Rho family
function [16,46,134–136], so only a very brief introduction,
rather than an in-depth analysis, will be included here. Rho
family GTPases couple extracellular signals (e.g. growth
factors, bioactive lipids, ECM), working through transmem-
brane receptors (e.g. RTKs, GPCRs, integrins), to the
formation and/or organization of higher-order actin struc-
tures. Specifically, Rho, Rac, and Cdc42 mediate the
formation of stress fibers, lamellipodia, and filopodia,
respectively.
4.2.1.1. Rho. The founding member of its family, the Rho
GTPase governs contractility-dependent processes in micro-
filament dynamics, including the formation of stress fibers
[16], tail and ruffle retraction during migration [124,125],
and corseting all but the protruding leading edge of the cell
periphery [137]. Rho also appears to have less well-under-
stood functions actually within the leading edge of migrat-
ing cells [138,139], a structure where the need for
contractile processes is less intuitive. Inhibition of Rho
function has been shown, in various systems, to inhibit
motility [136,140], while up-regulation of some Rho iso-
forms is correlated with high metastatic potential in certain
tumors [141,142].Rho can be directly phosphorylated by PKA at Ser188
near its C-terminus, and this modification may inhibit Rho
function in two ways. Phosphorylation of this site can
inhibit the interaction of Rho with its effector ROKa [29],
and conversely enhance its interaction with the Rho guanine
nucleotide dissociation inhibitor (RhoGDI), thereby promot-
ing its extraction from the cell membrane and translocation
into the cytoplasm [143,144]. In support of the latter
mechanism, inhibition of PKA enhances Rho translocation
to membrane ruffles in migrating colon carcinoma cells
[139]. In addition, the effects of cAMP elevation and/or
PKA activation on stress fiber disassembly and cell mor-
phology can be effectively blocked by expression of a
constitutively active G14V Rho mutant [145], a non-phos-
phorylatable S188A Rho mutant [144], or overexpression of
ROKa [29]. Because of the striking similarities between the
morphologies elicited by cAMP/PKA and C3 botulinum
toxin [145,146], which inactivates Rho by direct ADP
ribosylation, it is likely that inactivation of Rho is largely
responsible for some of the earliest observed gross effects of
cAMP and PKA on actin-based morphology and movement
[147–149].
Given the fact that Rho presides over stress fiber forma-
tion and that cAMP/PKA agonists have long and often been
observed to disrupt these structures, regulation of Rho
function clearly represents a major target for PKA in
cytoskeletal regulation. However, while Rho is a major,
important target for PKA, it is very clear (at least it should
be by the end of this article) that it is not the only one.
Interestingly, one very early report suggested that elevation
of cAMP had no effect on LPA-induced (and therefore Rho-
mediated) stress fiber formation [150]. Also, a very intrigu-
ing report demonstrated that the effect of forskolin (Fsk) on
stress fiber integrity and morphology of rat fibroblasts could
be reversed by calpeptin-mediated inhibition of the protein
tyrosine phosphatase (PTP) SHP-2 (Refs. [151,152]; see
Section 4.3.4.2 below). While the effect of calpeptin (typ-
ically an inhibitor of the Ca2 +-dependent protease calpain)
on Rho function, location, or phosphorylation was never
directly tested, there is no obvious mechanism through
which calpeptin or inhibition of SHP-2 would reverse
phosphorylation of Rho by PKA. Thus, the rescue of stress
fibers by calpeptin appears, at least in some instances, to be
‘epistatic’ to PKA-phosphorylation of Rho. Finally, the
same investigators who had previously reversed the mor-
phological effects of cAMP by expression of activated Rho
or ROKa [29] have recently reported that Cdc42, working
through the myotonic dystrophy kinase-related Cdc42-bind-
ing kinase (MRCK), can also counter the morphological
effects of cAMP [153]. Clearly, there are targets other than
Rho which mediate the effects of cAMP/PKA on cell
morphology.
Interestingly, a recent report has demonstrated that over-
expression of a particular AKAP, AKAP-Lbc, promotes
stress fiber assembly in a Rho-dependent manner, likely
by coupling the heterotrimeric G protein subunit Ga12 to
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and a positive and negative regulator (Ga12, PKA) suggests
a sophisticated mechanism of Rho regulation that involves
PKA and is capable of swift, sharp, and highly localized
dynamics.
4.2.1.2. Rac. Activity of the Rac GTPase promotes mem-
brane protrusion and the formation of lamellipodia and is
thus a critically important component of cell movement
[16,135]. As mentioned in Introduction, Rac activation
appears to be localized to leading edge structures in pro-
truding and/or migrating cells [14,15]. In contrast to its
inhibitory effects on Rho, PKA appears to be required
for activation of Rac in carcinoma and endothelial cells
[39,154]. There is, however, conflicting evidence that acti-
vation of PKA in endothelial cells can inhibit activation of
Rac and cell migration [155]. The reason for the disparity
between these observations is currently unknown.
Also unlike Rho, Rac itself is not directly phosphorylated
by PKA [144]. Therefore, the target for PKA that controls
Rac activation is currently unknown. It is interesting to note,
however, that Rac activity can be regulated by the protein
tyrosine phosphatase PTP-PEST [156], which is a substrate
for PKA (see Ref. [157] and below).
4.2.1.3. Cdc42. Cdc42 is the third major member of the
Rho family that presides over cytoskeletal dynamics and
cell migration, and that may be a target, albeit an indirect
one, for PKA. Cdc42 is most often associated with the
formation of filopodia and establishment of cell polarity in
preparation for chemotactic movement. Activation of
cAMP/PKA signaling has been shown to promote activa-
tion of Cdc42 in mast cells [38] and neurons [158]. Like
the situation for Rac, the exact mechanism of Cdc42
activation by cAMP/PKA is not clear, as Cdc42 is not
efficiently phosphorylated by PKA [38,144,159]. Alterna-
tively, activation of Cdc42 may involve PKA-dependent
modulation of phosphoinositol 3-kinase [158]. There is
additional complexity in the connection between Cdc42
and cAMP/PKA, however, as activated Cdc42 can also
antagonize cAMP-mediated morphological effects on a
neuroblastoma cell line in a manner dependent on the
myotonic dystrophy-related Cdc42-binding kinase MRCK
[153]. This complexity notwithstanding, the potential im-
portance of the connection between PKA and Cdc42 is
underscored by a recent report linking PKA via AKAP79 to
IQGAP-1, a cadherin- and microtubule-associated regulator
of cytoskeletal dynamics that is regulated by both Ca2 + and
Cdc42 [160].
4.2.2. PAK1
The p21-activated kinases (PAKs) [161] are major targets
for Rho-GTPases Rac and Cdc42 in regulation of actin
dynamics and cell migration. Their functions have been
implicated in the regulation of directionality/persistence of
movement [162], cell adhesion and contractility [163]. Theyare localized to actin-rich structures such as pseudopodia
and membrane ruffles [164] and auto-phosphorylated/acti-
vated forms are located to the leading edge of migrating
cells [162]. Activation of PKA by Fsk or following cellular
detachment promotes phosphorylation and inhibition of
p21-activated kinase-1 (PAK1) [41]. Interestingly, activation
of cAMP/PKA also decreases phosphorylation of the Ser/
Thr kinase Raf-1 on Ser338, an established target for PAK
phosphorylation (Ref. [165]; A. Howe (unpublished obser-
vations); M. Edin and R.L. Juliano (personal communica-
tion)). Another downstream target of PAK function, and one
more germane to matters of motility, is the LIM-domain
kinase (LIMK) family [166]. LIMKs are Ser kinases whose
activation correlates with accumulation of cortical F-actin.
This is due in large part to LIMK-mediated phosphorylation
of actin depolymerizing factor (ADF)/cofilin severing pro-
teins [167,168], which inhibits their severing activity and
allows filament elongation. PAK family members phosphor-
ylate and activate LIMK, thereby coupling Rac and Cdc42
to filament elongation [169–171]. Interestingly, elevation of
cAMP promotes dephosphorylation of ADF/cofilin during
neurite extension [172]. Though PKA-dependent activation
of protein phosphatase-1 (see Ref. [172] and below) is
thought to play a role in this event, it is tempting to consider
the contribution of decreased LIMK activity via PKA-
dependent inhibition of PAK, as well. PAKs have also been
demonstrated to be regulators of myosin function, through
either phosphorylation and inhibition of MLCK [173] or
direct phosphorylation of the myosin II regulatory light
chain [174], and thus form another potential connection
between PKA and myosin regulation (see above).
4.2.3. Src/CSK
A case that typifies the dichotomous nature of PKA
signaling is the PKA-dependent regulation of the Src non-
receptor tyrosine kinase. Src family kinases have been
implicated as important juxtamembrane signaling compo-
nents in adhesion, cytoskeletal dynamics, and movement
[175–177], through modification of central players such as
paxillin, p130CAS, Cbl, and FAK. PKA can phosphorylate
and activate the C-terminal Src kinase, Csk [178,179]. This,
in turn, promotes phosphorylation of a negative regulatory
tyrosine residue in the C-terminus of Src family kinase (e.g.
Src and Lck) and thus inhibition of Src kinase activity
[178,179]. This regulation occurs in membrane microdo-
mains with properties similar to lipid rafts [178], and results
in a PKA-mediated inhibition of Src-dependent phosphory-
lation of Cbl and FAK [178]. In contrast, PKA has been
reported to directly phosphorylate and activate Src, an event
linked to cAMP-dependent activation of Rap1 [180]. How-
ever, this report focused only on the role of the cAMP/PKA/
Src/Rap1 axis in regulation of ERK signaling and cell
proliferation. Therefore, the potential importance of this
mode of regulation, and the balance between PKA-depen-
dent activation and inhibition of Src activity, for cytoskeletal
remodeling has yet to be determined.
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PKA and Src. Because the SH3 domain of Src may interact
with VASP family proteins [88,98,181], there is the possi-
bility that PKA may impinge on Src function through
disruption of VASP–Src protein complexes, in a mechanism
analogous to that described above for VASP–Abl [42].
4.2.4. Tyrosine phosphatases
4.2.4.1. PTP-PEST. Within a year of its isolation and
cloning, PTP-PEST (protein tyrosine phosphatase contain-
ing a PEST degradation targeting sequence) was shown to
be phosphorylated (on Ser39) and inhibited by PKA [157].
Since then, PTP-PEST has been implicated as a critically
important regulator of cell motility [156,182,183], through
regulation of a number of substrates including the focal
adhesion adapter protein paxillin [184,185], the Wiskott–
Aldrich Syndrome protein (WASP) [186], p130CAS [187],
and likely many others [188,189]. PTP-PEST has also been
implicated as a regulator of Rac activity, likely through
dephosphorylation of p130CAS, which is critically important
for PTP-PEST-dependent cell motility [156]. PKA-mediated
inhibition of PTP-PESTwould, therefore, promote increased
tyrosine phosphorylation of relevant PTP-PEST substrates.
Given its importance in migration and its growing list of
high-profile targets (e.g. Rac [156]), PTP-PEST presents
itself as a very important potential target for PKA in
cytoskeletal/migratory dynamics.
4.2.4.2. SHP2. The SH2-domain containing phosphotyro-
sine phosphatase, SHP2, is another PTP implicated in a wide
variety of cell functions [190] including cell migration. In
migration, SHP2 appears to act specifically in the regulation
of integrin signaling, Rho activity, and de-adhesion
[152,191–193]. Unlike PTP-PEST, direct phosphorylation
of SHP2 by PKA stimulates its phosphatase activity [194].
An interesting potential target for SHP2 in this regard is
paxillin [195], the tyrosine phosphorylation of which is
negatively regulated by cAMP and PKA [41,196,197]. An-
other important consequence of the connection between PKA
and SHP2 comes from the observations of Schoenwaelder
and Burridge [151] and Schoenwaelder et al. [152]. In these
reports, activation of cAMP/PKA signaling in rodent fibro-
blasts by treatment with Fsk resulted in a characteristic loss of
stress fibers, which was blocked by calpeptin in a PTP-
dependent manner [151]. Subsequent work identified the
calpeptin-sensitive PTP as SHP2 and demonstrated that
SHP2 negatively regulates Rho function (and thus stress
fiber integrity), likely through dephosphorylation and inhi-
bition of a RhoGEF [152]. Significantly, because the effect of
Fsk is blocked solely by inhibition of SHP2 in this scenario,
PKA-mediated loss of stress fibers appears to be completely
independent of any PKA-mediated phosphorylation of Rho.
This reinforces the tenet that direct phosphorylation of Rho is
not the only mechanism through which PKA can regulate
stress fiber integrity.4.2.4.3. PTP1B. A third PTP to consider here is PTP1B
[198,199], which impinges on cytoskeletal regulation by
dephosphorylating the CrkII adapter protein [200], a key
regulator, along with p130CAS, of cell migration [113,201].
Specifically, PTP1B dephosphorylates the negative regula-
tory Tyr221 in Crk, allowing formation of Crk–Cas com-
plexes. The level of intracellular cAMP has been shown to
directly correlate with PTP1B activity [202]. This gives rise
to an intriguing scenario in which cAMP/PKA may, in
theory, regulate the formation of Crk–CAS complexes both
by inhibiting PTP-PEST-dependent dephosphorylation of
Cas (see above) and by promoting PTP1B-dependent de-
phosphorylation and activation of Crk.
4.2.5. Calpain
The Ca2 +-dependent cysteine protease calpain has, in
the past five or so years, been established as a critically
important regulator of cell migration [203,204]. Its two
major modes of action appear to be proteolysis of focal
adhesion components and contact disassembly or turnover,
especially during trailing edge retraction [205–208], as
well as regulation of integrin-mediated signaling upstream
of Rho family GTPases [209]. Although studying the
phosphorylation of calpain has proven to be difficult
(see Ref. [210] for a discussion), there is solid preliminary
evidence to suggest that calpain is phosphorylated by PKA
and that this modification reduces calpain activation [210–
212]. Thus, PKA activity, perhaps localized to various
subcellular locations by AKAPs, may limit calpain activity
and focal adhesion turnover in a spatially regulated
manner.
4.2.6. Rap1
A close member of the Ras superfamily, Rap1 was
originally identified as a protein that could revert the pheno-
type of K-ras-transformed cells [213]. Rap1 is now enjoying
the attention of the cell adhesion/cytoskeleton world, as a
number of studies have demonstrated that Rap1 regulates cell
adhesion (particularly that of immune cells) by modulating
integrin affinity or activation (e.g. Refs. [33,214–220];
reviewed in Refs. [213,221,222]). Rap1 activity and adhesive
function can be governed by C3G [223], a guanine nucleotide
exchange factor that is activated by the Crk adapter protein
(of Crk–130CAS fame) [113,217,224]. Important here is the
fact that Rap1 is also activated indirectly by cAMP [225] via
the exchange proteins activated by cAMP (EPACs; see
below) [226–229], and is a substrate for PKA [230,231],
though the exact consequence of this phosphorylation is
unknown. Another potential pathway connecting PKA and
Rap involves phosphorylation and activation of the Src
tyrosine kinase, which then promotes activation of Rap1 in
an EPAC-dependent manner [180]. The close connections
between cAMP/PKA and Rap1, and the growing importance
of Rap1 activity in modulating integrin-dependent adhesion,
establish this as an important potential axis of PKA-depen-
dent regulation of cell migration.
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While the focus of this review has been on the cAMP/
PKA signaling cascade, a growing number of PKA-inde-
pendent effects on the regulation of cytoskeleton, adhesion,
and migration were ascribed to cAMP. While PKA remains
the major effector for cAMP within cells, EPACs are
quickly emerging as important new effectors of adhesion
and thus, potentially, cell migration. The ability of EPACs
to act as guanine nucleotide exchange factors (and thus
activators) of Rap1 [228], coupled with the previous
discussion of the growing importance of Rap in integrin
mediated adhesion, establishes EPAC function as an im-
portant, cAMP-dependent but PKA-independent mecha-
nism for regulating migration. Indeed, EPACs appear to
be able to elicit Rap-dependent changes in cell adhesion
without any assistance from PKA [219,229]. An important
recent addition to this literature is the PKA-independent
activation of Rac through a cAMP/EPAC/Rap1-dependent
mechanism [232]. Of course, because nothing is simple,
there is now evidence that EPACs can function indepen-
dently of Rap activity to activate the Jun N-terminal kinase
(JNK) [233], another important regulator of cell migration
[234].
In balance to the PKA-independence of cAMP, there is
also evidence that PKA can, despite its name, be activated
independently of cAMP [235,236], most convincingly dem-
onstrated by the Ga13-dependent activation of PKA through
AKAP110 [237]. The importance of this mode of PKA
activation, or any other unconventional mechanisms of PKA
function [238], for regulation of cell migration and the
cytoskeleton remains to be seen.
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Regulation of intracellular cAMP and PKA varies
widely with cell type and cell environment. It is therefore
unlikely that the contributions of cAMP/PKA to cytoskel-
etal regulation and cell movement can be described in
sweeping statements derived from any single experimental
system. There are obvious omissions from the scope of
this article. Its focus has been the regulation of actin
microfilament dynamics, although it is clear that cAMP/
PKA also play important roles in regulating other elements
of the cytoarchitecture, including intermediate filaments
(e.g. through phosphorylation of keratin [239–241],
vimentin [242–244], and desmin [242–244]) and micro-
tubules (e.g. through phosphorylation of MAP-2[245,246]
and stathmin [247]). Regulation of microtubules is a
particularly germane consideration, considering the grow-
ing understanding of the cooperation and cross-talk be-
tween microtubules and microfilaments in regulating
protrusive cellular structures, i.e. dendrites, filopodia and
lamellipodia (e.g. Refs. [248–251]; reviewed in Refs.
[252–254]. Even within the broad confines of actin
dynamics, this article has not given detailed considerationto two crucially important, specialized systems—hemato-
poietic/immune cells and neuronal cells—in which cAMP/
PKA signaling plays principal roles (e.g. Refs. [255,256];
reviewed in Refs. [257,258]. Finally, this article has only
hinted at some of the major points of cross-talk between
cAMP/PKA and other major signaling cascades, such as
Ca2 + [27,259] and lipid signaling [128,260,261]. A vitally
important consideration from this latter point is the cross-
talk between PKA and PI3-K [261,262], especially given
the central role of PI3-K in directional sensing and
migration [2,5,263,264].
I end by underscoring what should be an obvious central
tenet of this review—the contribution of PKA to cytoskel-
etal and migratory dynamics is of considerable importance,
but is very complex, and likely to be signal-, cell type-, and
subcellular region-specific.References
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